{"context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "referenced_tweets": [{"type": "replied_to", "id": "1262118191452418048"}], "conversation_id": "1262118191452418048", "created_at": "2020-05-18T12:57:10.000Z", "author_id": "1158298350380150784", "in_reply_to_user_id": "17525171", "possibly_sensitive": false, "source": "Twitter for iPhone", "entities": {"mentions": [{"start": 0, "end": 8, "username": "Variety", "id": "17525171"}], "urls": [{"start": 116, "end": 139, "url": "https://t.co/qT95XMweDU", "expanded_url": "https://www.businesswire.com/news/home/20200518005348/en/Moderna-Announces-Positive-Interim-Phase-1-Data", "display_url": "businesswire.com/news/home/2020\u2026"}]}, "reply_settings": "everyone", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "text": "@Variety Moderna announces positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus https://t.co/qT95XMweDU", "id": "1262366622062309376", "lang": "en"}